Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study

Erythrodermic psoriasis (EP) is a dermatological emergency and its treatment with secukinumab is still controversial. Furthermore, no data exist regarding the prognostic value of drug abuse in such a condition. We performed a multi-center, international, retrospective study, enrolling a sample of EP...

Descripción completa

Detalles Bibliográficos
Autores principales: Damiani, Giovanni, Pacifico, Alessia, Russo, Filomena, Pigatto, Paolo Daniele Maria, Bragazzi, Nicola Luigi, Bonifati, Claudio, Morrone, Aldo, Watad, Abdulla, Adawi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617329/
https://www.ncbi.nlm.nih.gov/pubmed/31159169
http://dx.doi.org/10.3390/jcm8060770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617329/
https://www.ncbi.nlm.nih.gov/pubmed/31159169
http://dx.doi.org/10.3390/jcm8060770

Ejemplares similares